| Disease ID | Disease name | Source of annotation with FOXO1 | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 268220 | RHABDOMYOSARCOMA 2 | OMIM | link to OMIM | 3 | FOXO1, PAX7, PAX3 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Prostate cancer | hsa05215 | 6.11 |
| Pathways in cancer | hsa05200 | 3.98 |
| Transcriptional misregulation in cancer | hsa05202 | 5.21 |
| Insulin signaling pathway | hsa04910 | 5.55 |
| FoxO signaling pathway | hsa04068 | 5.63 |
| Thyroid hormone signaling pathway | hsa04919 | 5.82 |
| AMPK signaling pathway | hsa04152 | 5.8 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.66 |
| PI3K/AKT activation | R-HSA-198203 | 6.32 |
| Immune System | R-HSA-168256 | 2.37 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| GAB1 signalosome | R-HSA-180292 | 6.31 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
| Disease | R-HSA-1643685 | 3.33 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 10.98 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.54 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.81 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Regulation of beta-cell development | R-HSA-186712 | 7.98 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| GO term | GO ID | GO IC |
|---|---|---|
| ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
| enzyme binding | GO:0019899 | 2.27 |
| macromolecular complex binding | GO:0044877 | 2.61 |
| binding | GO:0005488 | 0.18 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding | GO:0001078 | 5.08 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| transcription factor activity, transcription factor binding | GO:0000989 | 3.36 |
| transcription factor activity, protein binding | GO:0000988 | 3.35 |
| transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding | GO:0000982 | 3.94 |
| RNA polymerase II transcription factor activity, sequence-specific DNA binding | GO:0000981 | 3.29 |
| transcription factor binding | GO:0008134 | 3.46 |
| beta-catenin binding | GO:0008013 | 5.3 |
| protein phosphatase binding | GO:0019903 | 4.93 |
| phosphatase binding | GO:0019902 | 4.63 |
| protein phosphatase 2A binding | GO:0051721 | 6.41 |
| transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding | GO:0001227 | 4.61 |
| ubiquitin protein ligase binding | GO:0031625 | 4.17 |
| transcription cofactor binding | GO:0001221 | 6.52 |
| transcription coactivator binding | GO:0001223 | 7.34 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| protein binding | GO:0005515 | 0.46 |
| chromatin binding | GO:0003682 | 3.64 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |